Register Login

All Posts

July 2025 CAP Today: A Deep Dive Into Key Hemostasis Testing Variables

Click A Deep Dive Into Key Hemostasis Testing Variables for an in-depth review of preanalytical hemostasis specimen concerns. The CAP article features Andrew Goodwin MD, professor, Department of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine, and medical director of the thrombosis and hemostasis section, University of Vermont Medical Center; and Dr. […]
read more

July 2025 QQ: Hemophilia Rebalancing Therapy

Our July 2025 Quick Question asked, “Which is a hemophilia ‘rebalancing’ therapeutic?” The question attracted a modest 22 participants, perhaps an indication that rebalancing therapy was only FDA-approved in 2025 and awaits approval in Canada and Europe. Here are your responses… Valoctocogene roxaparvovec-rvox (ROCTAVIAN) 3 (14%) Efanesoctocog alfa (ALTUVIIIO) 1 (4%) Emicizumab (HemLibra) 7 (32%) […]
read more